Skip Content
You are currently on the new version of our website. Access the old version .
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 21, Issue 2

2014 April - 30 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (30)

  • Article
  • Open Access
17 Citations
1,045 Views
4 Pages

Practice and Documentation of Palliative Sedation: A Quality Improvement Initiative

  • M. McKinnon,
  • C. Azevedo,
  • S.H. Bush,
  • P. Lawlor and
  • J. Pereira

1 April 2014

Background: Palliative sedation (ps), the continuous use of sedating doses of medication to intentionally reduce consciousness and relieve refractory symptoms at end of life, is ethically acceptable if administered according to standards of best prac...

  • Article
  • Open Access
13 Citations
1,253 Views
5 Pages

A Prior Diagnosis of Breast Cancer is a Risk Factor for Breast Cancer in Brca1 and Brca2 Carriers

  • S.A. Narod,
  • N. Tung,
  • J. Lubinski,
  • T. Huzarski,
  • M. Robson,
  • H.T. Lynch,
  • S.L. Neuhausen,
  • P. Ghadirian,
  • C. Kim–Sing and
  • + 2 authors

1 April 2014

Background: The risk of breast cancer in carriers of BRCA1 and BRCA2 mutations is influenced by factors other than the genetic mutation itself. Modifying factors include a woman’s reproductive history and family history of cancer. Risk factors are mo...

  • Article
  • Open Access
13 Citations
968 Views
8 Pages

Patient Perceptions of a Comprehensive Cancer Navigation Service

  • W. Hryniuk,
  • R. Simpson,
  • A. McGowan and
  • P. Carter

1 April 2014

(1) Objective: Our aim was to determine the extent to which comprehensive navigation augments the provincial health system for meeting the needs of newly-diagnosed cancer patients (clients). We also assessed reactions of attending physicians to compr...

  • Article
  • Open Access
2 Citations
857 Views
7 Pages

1 April 2014

Background: In 2006, perioperative epirubicin, cisplatin, and 5-fluorouracil (ECF), compared with surgery alone, demonstrated a significant survival benefit in resectable gastroesophageal cancers. We report the results of our experience with that pro...

  • Article
  • Open Access
22 Citations
1,470 Views
7 Pages

Can Oncologists Predict Survival for Patients with Progressive Disease After Standard Chemotherapies?

  • T.K. Taniyama,
  • K. Hashimoto,
  • N. Katsumata,
  • A. Hirakawa,
  • K. Yonemori,
  • M. Yunokawa,
  • C. Shimizu,
  • K. Tamura,
  • M. Ando and
  • Y. Fujiwara

1 April 2014

Background: Prediction of prognosis is important for patients so that they can make the most of the rest of their lives. Oncologists could predict survival, but the accuracy of such predictions is unclear. Methods: In this observational prospective c...

  • Article
  • Open Access
18 Citations
1,217 Views
6 Pages

1 April 2014

Repair of radiation-induced dna double-strand breaks is a key mechanism in cancer cell radioresistance. The synthesized compound NU7026 specifically inhibits dna-dependent protein kinase (dna-pk) within the non-homologous end-joining repair mechanism...

  • Article
  • Open Access
16 Citations
1,074 Views
7 Pages

Prospective Evaluation of Unmet Needs of Rural and Aboriginal Cancer Survivors in Northern British Columbia

  • R.A. Olson,
  • F. Howard,
  • K. Turnbull,
  • D. Munroe,
  • C. Zirul,
  • R. Manji,
  • P. Tobin and
  • A. Ward

1 April 2014

Background: The unmet needs of cancer survivors in rural, remote, and aboriginal communities are largely unexplored. We explored potential differences between rural survivors (rss) in 4 general population (gp) and 4 First Nations (fn) communities. Me...

  • Article
  • Open Access
10 Citations
1,057 Views
9 Pages

1 April 2014

Background: Reliable and valid assessment of the disease burden across all forms of cancer is critical to the evaluation of treatment effectiveness and patient progress. The Edmonton Symptom Assessment System (esas) is used for routine evaluation of...

  • Article
  • Open Access
1 Citations
850 Views
8 Pages

1 April 2014

Background: Surgery is a cornerstone of cancer treatment, but significant differences in the quality of surgery have been reported. Surgical process improvement tools (spits) modify the processes of care as a means to quality improvement (qi). We wer...

  • Article
  • Open Access
25 Citations
1,543 Views
9 Pages

Patients’ Perceptions of Gene Expression Profiling in Breast Cancer Treatment Decisions

  • Y. Bombard,
  • L. Rozmovits,
  • M.E. Trudeau,
  • N.B. Leighl,
  • K. Deal and
  • D.A. Marshall

1 April 2014

Introduction: Determining the likely benefit of adjuvant chemotherapy for early-stage breast cancer patients depends on estimating baseline recurrence risk. Gene expression profile (gep) testing of tumours informs risk prediction, but evidence of its...

  • Article
  • Open Access
14 Citations
930 Views
9 Pages

1 April 2014

Background: Cancer survivors (css) are frequently exposed to polypharmacy, which might increase their risk of drug interactions. Our study aimed to determine the relative prevalence of potential drug interactions (pdis) among css compared with non-ca...

  • Article
  • Open Access
13 Citations
1,236 Views
8 Pages

Toward Successful Migration to Computerized Physician Order Entry for Chemotherapy

  • J. Jeon,
  • S. Taneva,
  • V. Kukreti,
  • P. Trbovich,
  • A.C. Easty,
  • P.G. Rossos and
  • J.A. Cafazzo

1 April 2014

Backgroud: Computerized physician order entry (cpoe) systems allow for medical order management in a clinical setting. Use of a cpoe has been shown to significantly improve chemotherapy safety by reducing the number of prescribing errors. Usability o...

  • Article
  • Open Access
5 Citations
931 Views
12 Pages

The Use of Granulocyte Colony–Stimulating Factors in a Canadian Outpatient Setting

  • S. Fine,
  • M. Koo,
  • T. Gill,
  • M. Marin,
  • M. Poulin–Costello,
  • R. Barron and
  • N. Mittmann

1 April 2014

Background: Data on real-life utilization of granulocyte colony– stimulating factors (g-csfs) in Canada are limited. The objective of the present study was to describe the reasons for, and the patterns of, g-csf use in selected outpatient oncology cl...

  • Article
  • Open Access
23 Citations
1,250 Views
9 Pages

Patient preferences for stopping tyrosine kinase inhibitors in chronic myeloid leukemia

  • D. Sanford,
  • R. Kyle,
  • A. Lazo–Langner,
  • A. Xenocostas,
  • I. Chin–Yee,
  • K. Howson–Jan and
  • C. Hsia

1 April 2014

Background: We used an interview-assisted survey of patients with chronic myeloid leukemia (cml) at a single tertiary care centre to explore patient reactions to and preferences for, and the risk-acceptability of, stopping tyrosine kinase inhibitor (...

  • Article
  • Open Access
14 Citations
866 Views
5 Pages

1 April 2014

Backgroud: We set out to determine the rate, time-trend, and defining factors associated with publication of abstracts presented at two annual scientific meetings of the Canadian Association of Radiation Oncology (caro). Methods: All abstracts accept...

  • Review
  • Open Access
45 Citations
1,582 Views
10 Pages

The Road Ahead for Cervical Cancer Prevention and Control

  • J.E. Tota,
  • A.V. Ramana–Kumar,
  • Z. El-Khatib and
  • E.L. Franco

1 April 2014

Since the early 1950s, Papanicolaou (“Pap”) cytology screening has dramatically reduced cervical cancer mortality in most high-income settings. Currently, human papillomavirus (hpv) vaccination has the greatest potential to reduce the global burden o...

  • Article
  • Open Access
14 Citations
1,342 Views
45 Pages

1 April 2014

Adult Philadelphia chromosome–positive (Ph+) or BCR-ABL–positive (BCR-ABL+) acute lymphoblastic leukemia (ALL) is an acute leukemia previously associated with a high relapse rate, short disease-free survival, and poor overall survival. In adults, all...

  • Article
  • Open Access
28 Citations
1,122 Views
4 Pages

Predictors of Recurrence after Radiotherapy for Non-Melanoma Skin Cancer

  • L. Khan,
  • D. Breen,
  • L. Zhang,
  • J. Balogh,
  • G. Czarnota,
  • J. Lee,
  • M.N. Tsao and
  • E.A. Barnes

1 April 2014

Predictive factors of recurrence were examined in 448 non-melanoma skin cancers (72% basal cell carcinoma, 28% squamous cell carcinoma) treated with radiotherapy. The overall recurrence rate was 15.8% at a median follow-up of 18.4 months. In multivar...

  • Article
  • Open Access
28 Citations
1,168 Views
4 Pages

1 April 2014

Distress has been declared the 6th vital sign in Canadian cancer care. Accordingly, health care professionals in Canada are expected to screen for distress in patients with cancer, for which a toolkit has been developed. Identifying patients who may...

  • Article
  • Open Access
21 Citations
1,180 Views
6 Pages

1 April 2014

Patients undergoing myeloablative conditioning regimens and autologous stem-cell transplantation (ASCT) are at high risk of malnutrition. This randomized study aimed to determine if early nutrition support (commenced when oral intake is less than 80%...

  • Article
  • Open Access
4 Citations
939 Views
5 Pages

Metabolic Syndrome–Related Hepatocellular Carcinoma Treated by Volumetric Modulated Arc Therapy

  • J. Klein,
  • L.A. Dawson,
  • T.H. Tran,
  • O. Adeyi,
  • T. Purdie,
  • M. Sherman and
  • A. Brade

1 April 2014

Hepatocellular carcinoma (hcc) is a leading cause of cancer mortality, and its incidence is increasing in developed countries. Risk factors include cirrhosis from viral hepatitis or alcohol abuse. Metabolic syndrome is a newly recognized, but importa...

  • Article
  • Open Access
2 Citations
1,005 Views
4 Pages

fdg-pet in Two Cases of Neurofibromatosis Type 1 and Atypical Malignancies

  • P. de Blank,
  • K. Cole,
  • L. Kersun,
  • A. Green,
  • J.J. Wilkes,
  • J. Belasco,
  • R. Bagatell,
  • L.C. Bailey and
  • M.J. Fisher

1 April 2014

Patients with neurofibromatosis type 1 (NF1) are at increased risk for both benign and malignant tumours, and distinguishing the malignant potential of an individual tumour is a common clinical problem in these patients. Here, we review two cases of...

  • Case Report
  • Open Access
8 Citations
857 Views
5 Pages

1 April 2014

Li–Fraumeni syndrome is an autosomal dominant disorder characterized by germline TP53 mutation and increased susceptibility to cancer. Despite certain in vitro findings and a theoretical rationale for patients with TP53 mutation to be more radiosensi...

  • Case Report
  • Open Access
8 Citations
942 Views
4 Pages

1 April 2014

Because of common risk factors, synchronous squamous cell carcinomas of the esophagus and head and neck are common, and their concurrent presence can significantly complicate disease eradication and survival. Here, we report the case of a patient wit...

  • Meeting Report
  • Open Access
1 Citations
1,980 Views
34 Pages

1 April 2014

Objectives: It is estimated that 1–2% of individuals of Ashkenazi Jewish (AJ) ancestry carry one of three pathogenic founder mutations in BRCA1 and BRCA2. Targeted testing for these mutations (BRCA1 187delAG and 5385insC, and BRCA2 6174delT) is there...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729